1-150806803-C-T

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000396.4(CTSK):​c.3G>A​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

CTSK
NM_000396.4 start_lost

Scores

4
6
7

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 2.87

Publications

2 publications found
Variant links:
Genes affected
CTSK (HGNC:2536): (cathepsin K) The protein encoded by this gene is a lysosomal cysteine proteinase involved in bone remodeling and resorption. This protein, which is a member of the peptidase C1 protein family, is predominantly expressed in osteoclasts. However, the encoded protein is also expressed in a significant fraction of human breast cancers, where it could contribute to tumor invasiveness. Mutations in this gene are the cause of pycnodysostosis, an autosomal recessive disease characterized by osteosclerosis and short stature. [provided by RefSeq, Apr 2013]
CTSK Gene-Disease associations (from GenCC):
  • pycnodysostosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Genomics England PanelApp, Ambry Genetics, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 30 pathogenic variants. Next in-frame start position is after 75 codons. Genomic position: 150806122. Lost 0.225 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-150806803-C-T is Pathogenic according to our data. Variant chr1-150806803-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 551777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTSKNM_000396.4 linkc.3G>A p.Met1? start_lost Exon 2 of 8 ENST00000271651.8 NP_000387.1 P43235

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTSKENST00000271651.8 linkc.3G>A p.Met1? start_lost Exon 2 of 8 1 NM_000396.4 ENSP00000271651.3 P43235

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251234
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000889
AC:
13
AN:
1461586
Hom.:
0
Cov.:
32
AF XY:
0.00000825
AC XY:
6
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53126
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000899
AC:
10
AN:
1112004
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyknodysostosis Pathogenic:3
May 10, 2017
Counsyl
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Apr 11, 2023
Genome-Nilou Lab
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 06, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CTSK c.3G>A (p.Met1Ile) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The next downstream in-frame start Met is located at codon 75. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251234 control chromosomes (gnomAD). c.3G>A has been reported in the literature in individuals affected with Pyknodysostosis (Arman_2014, Al-Araimi_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 35186389, 24767306, 33945887). ClinVar contains an entry for this variant (Variation ID: 551777). Based on the evidence outlined above, the variant was classified as likely pathogenic. -

not provided Pathogenic:1
Mar 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects the initiator methionine of the CTSK mRNA. The next in-frame methionine is located at codon 75. This variant is present in population databases (rs778368118, gnomAD 0.003%). Disruption of the initiator codon has been observed in individual(s) with pycnodysostosis (PMID: 24767306). ClinVar contains an entry for this variant (Variation ID: 551777). This variant disrupts a region of the CTSK protein in which other variant(s) (p.Arg46Trp) have been determined to be pathogenic (PMID: 17206399, 24269275, 27092432). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T;T
Eigen
Benign
-0.042
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D;T
M_CAP
Pathogenic
0.63
D
MetaRNN
Pathogenic
0.97
D;D
MetaSVM
Benign
-0.74
T
PhyloP100
2.9
PROVEAN
Benign
-0.77
N;N
REVEL
Uncertain
0.42
Sift
Uncertain
0.010
D;D
Sift4G
Uncertain
0.057
T;.
Polyphen
0.0010
B;.
Vest4
0.94
MutPred
0.90
Gain of catalytic residue at M1 (P = 0.0137);.;
MVP
0.76
ClinPred
0.97
D
GERP RS
4.6
PromoterAI
-0.0079
Neutral
Varity_R
0.49
gMVP
0.65
Mutation Taster
=13/187
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs778368118; hg19: chr1-150779279; API